CXCL1 and breast cancer: XIAOPI formula reduces the activation of hematopoietic stem/progenitor cells and their differentiation into MDSCs to prevent the formation of BC PMNs by suppressing the TAMs/CXCL1 signaling, indicating the potential of TAMs/CXCL1 as a therapeutic target in BC metastasis 121.